FENNEC PHARMACEUTICALS INC. — Director's Dealing 2023

Dec 29, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2023-12-28

Reporting Person: Raykov Rosty (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-28	Common shares	M	8540	$1.59	Acquired	291127	Direct
2023-12-28	Common shares	S	3656	$11.55	Disposed	287471	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-28	Commons Shares	$1.59	M	8540	Acquired	2024-01-24	options (8540)	Direct

Footnotes

F1: Shares acquired through the exercise of an option contract with strike price of $1.59 and an expiration date of January 24, 2024.

F2: Shares sold to satisfy tax obligation on option exercise.

F3: Represents options granted on January 24, 2014, with a strike price of $1.59 and an expiration date of January 24, 2024.